FLT3 receptor expression on the surface of normal and malignant human hematopoietic cells

Blood

Volumn 88, Issue 9, 1996, Pages 3383-3390

  Turner, Anne M ^a   Lin, Nancy L ^a   Issarachai, Surasit ^a   Lyman, Stewart D ^a   Broudy, Virginia C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR; HEMOPOIETIC GROWTH FACTOR; MESSENGER RNA; RECOMBINANT STEM CELL FACTOR; RECOMBINANT THROMBOPOIETIN;

ARTICLE; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LIGAND BINDING; MEGAKARYOPOIESIS; MONONUCLEAR CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 0029998037     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.9.3383.bloodjournal8893383     Document Type: Article

References (45)

1. Maroc N, Rottapel R, Rosnet O, Marchetto S, Lavezzi C, Mannoni P, Birnbaum D, Dubreuil P: Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase. Oncogene 8:909, 1993
2. Rosnet O, Marchetto S, deLapeyriere O, Birnbaum D: Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family. Oncogene 6:1641, 1991
3. Lyman SD, James L, Bos TV, de Vries P, Brasel K, Gliniak B, Hollingsworth LT, Picha KS, McKenna HJ, Splett RR, Fletcher FA, Maraskovsky E, Farrah T, Foxworthe D, Williams DE, Beckmann MP: Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell 75:1157, 1993
4. + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 91:459, 1994
5. Zeigler FC, Bennett BD, Jordan CT, Spencer SD, Baumhueter S, Carroll KJ, Hooley J, Bauer K, Matthews W: Cellular and molecular characterization of the role of the FLK-2/FLT-3 receptor tyrosine kinase in hematopoietic stem cells. Blood 84:2422, 1994
6. Hirayama F, Lyman SD, Clark SC, Ogawa M: The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors. Blood 85:1762, 1995
7. Jacobsen SEW, Okkenhaug C, Myklebust J, Veiby OP, Lyman SD: The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: Synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors. J Exp Med 181:1357, 1995
8. Hudak S, Hunte B, Culpepper J, Menon S, Hannum C, Thompson-Snipes L, Rennick D: FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units. Blood 85:2747, 1995
9. Piacibello W, Fubini L, Sanavio F, Brizzi MF, Severino A, Garetto L, Stacchini A, Pegoraro L, Aglietta M: Effects of human FLT3 ligand on myeloid leukemia cell growth: Heterogeneity in response and synergy with other hematopoietic growth factors. Blood 86:4105, 1995
10. Rasko JEJ, Metcalf D, Rossner MT, Begley CG, Nicola NA: The flt3/flk-2 ligand: Receptor distribution and action on murine haemopoietic cell survival and proliferation. Leukemia 9:2058, 1995
11. + hematopoietic progenitor cells. Blood 86:3413, 1995
12. Hunte BE, Hudak S, Campbell D, Xu Y, Rennick D: flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors. J Immunol 156:489, 1995
13. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR: Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3:147, 1995
14. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR: A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65:1143, 1991
15. Birg F, Courcoul M, Rosnet O, Bardin F, Pèbusque M-J, Marchetto S, Tabilio A, Mannoni P, Birnbaum D: Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood 80:2584, 1992
16. Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J, Luh J, Duda G, Martina N, Peterson D, Menon S, Shanafelt A, Muench M, Kelner G, Namikawa R, Rennick D, Roncarolo M-G, Zlotnik A, Rosnet O, Dubreuil P, Birnbaum D, Lee F: Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368:643, 1994
17. DaSilva N, Hu Z-B, Ma W, Rosnet O, Birnbaum D, Drexler HG: Expression of the FLT3 gene in human leukemia-lymphoma cell lines. Leukemia 8:885, 1994
18. Iwama A, Okano K, Sudo T, Matsuda Y, Suda T: Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells. Blood 83:3160, 1994
19. Meierhoff G, Dehmel U, Gruss H-J, Rosnet O, Birnbaum D, Quentmeier H, Dirks W, Drexler HG: Expression of FLT3 receptor and FLT-ligand in human leukemia-lymphoma cells. Leukemia 9:1368, 1995
20. Carow CE, Levenstein M, Kaufmann SH, Chen J, Amin S, Rockwell P, Witte L, Borowitz MJ, Civin CI, Small D: Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias. Blood 87:1089, 1996
21. Papayannopoulou T, Nakamoto B, Kurachi S, Tweeddale M, Messner H: Surface antigenic profile and globin phenotype of two new human erythroleukemia lines: Characterization and interpretations. Blood 72:1029, 1988
22. Avanzi GC, Brizzi MF, Giannotti J, Ciarletta A, Yang Y-C, Pegoraro L, Clark SC: M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3. J Cell Physiol 145:458, 1990
23. Papayannopoulou T, Brice M, Broudy VC, Zsebo KM: Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: Functional properties and composite antigenic profile. Blood 78:1403, 1991
24. Smith FO, Broudy VC, Zsebo KM, Lampkin BC, Buckley CV, Buckley JD, Opie T, Woods WG, Hammond GD, Bernstein ID: Cell surface expression of c-kit receptors by childhood acute myeloid leukemia blasts is not of prognostic value: A report from the Children's Cancer Group. Blood 84:847, 1994
25. Calvo JC, Radicella JP, Charreau EH: Measurement of specific radioactivities in labeled hormones by self-displacement analysis. Biochemistry 212:259, 1983
26. Broudy VC, Morgan DA, Lin N, Zsebo KM, Jacobsen FW, Papayannopoulou T: Stem cell factor influences the proliferation and erythroid differentiation of the MB-02 human erythroleukemia cell line by binding to a high-affinity c-kit receptor. Blood 82:436, 1993
27. Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC: Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 80:374, 1992
28. Munson PJ, Rodbard D: Ligand: A versatile computerized approach for characterization of ligand-binding systems. Analyt Biochem 107:220, 1980
29. Broudy VC, Lin N, Brice M, Nakamoto B. Papayannopoulou T: Erythropoietin receptor characteristics on primary human erythroid cells. Blood 77:2583, 1991
30. I25I-labeled granulocyte colony-stimulating factor to normal murine hemopoietic cells. J Cell Physiol 124:313, 1985
31. 125I-insulin in adipocytes and IM-9 lymphocytes. J Biol Chem 257:8667, 1982
32. Lyman SD, James L, Johnson L, Brasel K, de Vries P, Escobar SS, Downey H, Splett RR, Beckmann MP, McKenna HJ: Cloning of the human homologue of the murine flt3 ligand: A growth factor for early hematopoietic progenitor cells. Blood 83:2795, 1994
33. Broudy VC, Lin NL, Kaushansky K: Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin. stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 85:1719, 1995
34. Burstein SA, Mei R-L, Henthorn J, Friese P, Turner K: Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakaryocytes in vitro. J Cell Physiol 153:305, 1992
35. Broudy VC, Smith FO, Lin N, Zsebo KM, Egrie J, Bernstein ID: Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor. Blood 80:60, 1992
36. Broudy VC, Lin N, Zsebo KM, Birkett NC, Smith KA, Bernstein ID, Papayannopoulou T: Isolation and characterization of a monoclonal antibody that recognizes human c-kit receptor. Blood 79:338, 1992
37. Brasel K, Escobar S, Anderberg R, de Vries P, Gruss H-J, Lyman SD: Expression of the flt3 receptor and its ligand on hematopoietic cells. Leukemia 9:1212, 1995
38. Turner AM, Bennett LG, Lin NL, Wypych J, Bartley TD, Hunt RW, Atkins HL, Langley KE, Parker V, Martin F, Broudy VC: Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines. Blood 85:2052, 1995
39. Li W, Stanley ER: Role of dimerization and modification of the CSF-1 receptor in its activation and internalization during the CSF-1 response. EMBO J 10:277, 1991
40. Blume-Jensen P, Claesson-Welch L, Siegbahn A, Zsebo KM, Westermark B, Heldin C-H: Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis. EMBO J 10:4121, 1991
41. Yee NS, Langen H, Besmer P: Mechanism of kit ligand, phorbol ester, and calcium induced down-regulation of c-kit receptors in mast cells. J Biol Chem 268:14189, 1993
42. Piacibello W, Garetto L, Sanavio F, Severino A, Fubini L, Stacchini A, Dragonetti G, Aglietta M: The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis. Exp Hematol 24:340, 1996
43. Ratajczak MZ, Ratajczak J, Ford J, Kregenow R. Marlicz W, Gewirtz M: FLT3/FLK-2 (STK-1) ligand does not stimulate human megakaryopoiesis in vitro. Stem Cells 14:146, 1996
44. Lyman SD, Brasel K, Rousseau A-M, Williams DE: The flt3 ligand: A hematopoietic stem cell factor whose activities are distinct from steel factor. Stem Cells 12:99, 1994 (suppl)
45. Abkowitz JL, Broudy VC, Bennett LG, Zsebo KM, Martin FH: Absence of abnormalities of c-kit or its ligand in two patients with Diamond-Blackfan anemia. Blood 79:25, 1992